Systems Medicine, a Novel Approach to Chronic Diseases: the example of PLP10 Multiple Sclerosis intervention treatment, a phase II clinical trial
A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomized, double-blind, placebo-controlled proof-of-concept clinical trial. Greek Neurological Society
A novel oral medical nutrition formula (PLP10) for the treatment of relapsing-remitting multiple sclerosis: a randomized, double-blind, placebo-controlled proof-of-concept clinical trial
Pioneer oral nutraceutical formula (PLP10) for the treatment of relapsing remitting multiple sclerosis: A randomized, double-blind, placebocontrolled proof-of-concept clinical trial
A novel oral medical nutrition formula (PLP10) for the treatment of relapsing remitting multiple sclerosis: a randomized, double-blind, placebocontrolled proof-of-concept clinical trial
A Pioneer Nutraceutical Formula (PLP10) for the Treatment of Relapsing Remitting Multiple Sclerosis: A Randomized, Double Blind, Placebo Controlled Proof-of-Concept Clinical Trial
